ArticleRegenerative biomaterials2023

Hybrid liposome-erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation.

Kehui Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.